Variables | Controlled triple target | Controlled FBG | Controlled HbA1c | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CI | SE | P-value | p-value (Comparison) | CI | SE | P-value | p-value (Comparison) | CI | SE | P-value | p-value (Comparison) | |
Total | 0.1067 | 0.0198 | < 0.001 | - | 0.0125 | 0.0071 | 0.078 | - | 0.0324 | 0.0083 | 0.0001 | - |
Sex | ||||||||||||
Women | 0.209 | 0.0278 | < 0.001 | < 0.001 | 0.0367 | 0.0095 | 0.0001 | 0.0035 | 0.0745 | 0.0114 | < 0.001 | < 0.001 |
Men | -0.0002 | 0.028 | 0.993 | -0.0048 | 0.0106 | 0.648 | -0.0111 | 0.0122 | 0.363 | |||
Age group (years) | ||||||||||||
35–45 | 0.376 | 0.0467 | < 0.001 | 0.006 | -0.009 | 0.019 | 0.641 | 0.222 | 0.0223 | 0.0188 | 0.236 | 0.260 |
46–55 | 0.0357 | 0.0301 | 0.236 | 0.0116 | 0.0121 | 0.339 | 0.0607 | 0.0142 | < 0.001 | |||
56–65 | 0.045 | 0.043 | 0.299 | 0.0019 | 0.0125 | 0.873 | 0.0022 | 0.0162 | 0.890 | |||
66–75 | 0.124 | 0.049 | 0.012 | 0.0708 | 0.0158 | < 0.001 | 0.0360 | 0.0194 | 0.064 | |||
Place of Residence | ||||||||||||
Rural | 0.0029 | 0.044 | 0.947 | 0.059 | -0.044 | 0.0142 | 0.002 | 0.001 | -0.0576 | 0.0172 | 0.0009 | < 0.001 |
Urban | 0.0967 | 0.023 | < 0.001 | 0.009 | 0.008 | 0.276 | 0.0306 | 0.0096 | 0.0015 | |||
Region | ||||||||||||
Low prevalence | 0.0681 | 0.0369 | 0.065 | 0.425 | -0.0277 | 0.0127 | 0.0316 | 0.001 | 0.0086 | 0.0155 | 0.577 | 0.514 |
Medium prevalence | 0.0586 | 0.0331 | 0.077 | 0.0009 | 0.0123 | 0.940 | 0.0534 | 0.0141 | 0.0002 | |||
High prevalence | 0.124 | 0.0347 | 0.0003 | 0.0186 | 0.0124 | 0.132 | 0.0262 | 0.0146 | 0.0727 |